Met proto-oncogene juxtamembrane rare variations in mouse and humans: Differential effects of Arg and Cys alleles on mouse lung tumorigenesis

Oncogene

Volumn 24, Issue 6, 2005, Pages 1084-1090

  Zaffaroni, Daniela ^a   Spinola, Monica ^a   Galvan, Antonella ^a   Falvella, F Stefania ^a   Pazzaglia, Simonetta ^b   Saran, Anna ^b   Mancuso, Maria Teresa ^b   Galbiati, Federica ^a   Pignatiello, Carmen ^a   Cabrera, Wafa ^c   Ibanez, Olga ^c   Manenti, Giacomo ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cancer modifier loci; Polygenic inheritance; Susceptibility to disease

Indexed keywords

ARGININE; CYSTEINE; GENE PRODUCT; GENOMIC DNA; PROTEIN PAR4; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; GROWTH FACTOR RECEPTOR; MET PROTEIN, HUMAN; ONCOPROTEIN; PROTEASE-ACTIVATED RECEPTOR 4; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE LOCUS; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; ADENOCARCINOMA; ANIMAL; CELL TRANSFORMATION; COMPARATIVE STUDY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOLECULAR GENETICS; MULTIFACTORIAL INHERITANCE; MUTATION; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ALLELES; AMINO ACID SEQUENCE; ANIMALS; ARGININE; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LINKAGE (GENETICS); LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MULTIFACTORIAL INHERITANCE; PROTO-ONCOGENE PROTEINS; RECEPTORS, GROWTH FACTOR; RECEPTORS, THROMBIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 13944257764     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208324     Document Type: Article

References (26)

1. Biozzi G, Ribeiro OG, Saran A, Araujo ML, Maria DA, De Franco M, Cabrera WK, Sant'anna OA, Massa S, Covelli V, Mouton D, Neveu T, Siqueira M and Ibanez OM. (1998). Carcinogenesis, 19, 337-346.
2. De Gregorio L, Manenti G, Incarbone M, Pilotti S, Pastorino U, Pierotti MA and Dragani TA. (1998). Int. J. Cancer, 79, 269-272.
3. Devereux TR, Wiseman RW, Kaplan N, Garren S, Foley JF, White CM, Anna C, Watson MA, Patel A, Jarchow S, Maronpot RR and Anderson MW. (1994). Mamm. Genome, 5, 749-755.
4. Dragani TA. (2003). Cancer Res., 63, 3011-3018.
5. Festing MFW, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM and You M. (1998). Genomics, 53, 129-136.
6. Gandino L, Longati P, Medico E, Prat M and Comoglio PM. (1994). J. Biol. Chem., 269, 1815-1820.
7. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G and Dragani TA. (1993). Nat. Genet., 3, 132-136.
8. Gariboldi M, Spinola M, Milani S, Pignatiello C, Kadota K, Bono H, Hayashizaki Y, Dragani TA and Okazaki Y. (2003). Carcinogenesis, 24, 1819-1826.
9. Lee JH, Han SU, Cho H, Jennings B, Gerrard B, Dean M, Schmidt L, Zbar B and Vande Woude GF. (2000). Oncogene, 19, 4947-4953.
10. Lincoln SE, Daly M, Lander ES and Anonymous. (1992). Mapping genes controlling quantitative traits with MAP-MAKER/QTL 1.1. Whitehead Institute Technical Report.
11. Longati P, Comoglio PM and Bardelli A. (2001). Curr. Drug Targets, 2, 41-55.
12. Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE and Salgia R. (2003). Cancer Res., 63, 6272-6281.
13. Manenti G, Acevedo A, Galbiati F, Gianni Barrera R, Noci S and Dragani TA. (2002). Int. J. Cancer, 99, 555-559.
14. Manenti G and Dragani TA. (2004). Carcinogenesis (in press).
15. Manenti G, Falvella FS, Gariboldi M, Dragani TA and Pierotti MA. (1995). Genomics, 29, 438-444.
16. Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA and Dragani TA. (1997a). Cancer Res., 57, 4164-4166.
17. Manenti G, Gariboldi M, Fiorino A, Zedda AI, Pierotti MA and Dragani TA. (1997b). Mamm. Genome, 8, 801-809.
18. Manenti G, Nomoto T, De Gregorio L, Gariboldi M, Stefania FF, Nagao M and Dragani TA. (2000). Toxicol. Lett., 112-113, 257-263.
19. Maria DA, Manenti G, Galbiati F, Ribeiro OG, Cabrera WK, Gianni Barrera R, Pettinicchio A, De Franco M, Starobinas N, Siqueira M, Dragani TA and Ibanez OM. (2003). Oncogene, 22, 426-432.
20. Obata M, Nishimori H, Ogawa K and Lee GH. (1996). Oncogene, 13, 1599-1604.
21. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY and Park M. (2001). Mol. Cell, 8, 995-1004.
22. Saran A, Neveu T, Covelli V, Mouton D, Pazzaglia S, Rebessi S, Doria G and Biozzi G. (2000). Int. J. Cancer, 88, 424-431.
23. Saran A, Zaffaroni D, Pazzaglia S, Peissel B, Galbiati F, Spinola M, Manenti G, Zanesi N, Rebessi S, Mancuso MT, Covelli V and Dragani TA. (2002). Int. J. Cancer, 97, 580-583.
24. Shultz KL, Donahue LR, Bouxsein ML, Baylink DJ, Rosen CJ and Beamer WG. (2003). J. Bone Mineral Res., 18, 175-185.
25. Weidner KM, Sachs M, Riethmacher D and Birchmeier W. (1995). Proc. Natl. Acad. Sci. USA, 92, 2597-2601.
26. Zhang Z, Lin L, Liu G, Wang M, Hill J, Wang Y, You M and Devereux TR. (2000). Exp. Lung Res., 26, 627-639.